NCT01059591 - First Study in Humans With GSK424887 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 25, 2006

Primary Completion Date

January 25, 2007

Study Completion Date

January 25, 2007

Conditions

Depressive Disorder and Anxiety Disorders

Interventions

DRUG

GSK424887

GSK424887 2mg, 10mg, 50mg, 100mg capsule

DRUG

Placebo

Placebo to match GSK424887 2mg, 10mg,50mg, 100mg capsule

RADIATION

PET

Each subject will undergo 3 PET scans : one at Baseline and the others following dosing with GSK424887 at approximately 2h post-dose and aproximately 24 hours post-dose

Trial Locations (1)

SE1 1YR

GSK Investigational Site, London